The ticker "RXRX" refers to Recursion Pharmaceuticals, Inc., which is listed on the NasdaqGS.
As of the most recent filings, Recursion Pharmaceuticals, Inc. (RXRX) has a significant institutional presence. There are 527 institutional owners and shareholders who have filed 13D/G or 13F forms with the SEC, holding a total of 352,884,183 shares.
The largest institutional holders of RXRX include:
- ARK Investment Management LLC
- Vanguard Group Inc
- Baillie Gifford & Co
- BlackRock, Inc.
- ARKK - ARK Innovation ETF
- Softbank Group Corp
- Kinnevik AB (publ)
- State Street Corp
- Mubadala Investment Co PJSC
- ARKG - ARK Genomic Revolution ETF
It's worth noting that institutional ownership can fluctuate. For instance, ARK Investment Management LLC increased its holdings by 40.17% in a recent filing, while RA CAPITAL MANAGEMENT, L.P. decreased its position by nearly 50% in the same period.
Understanding institutional ownership patterns can provide insights into how large, sophisticated investors view a company. Fintel's platform offers detailed breakdowns of institutional ownership, including 13F and 13D/G filings, to help track these movements and identify potential trends. You can explore the full details and historical changes on the Fintel RXRX ownership page.
